Previous 10 | Next 10 |
2023-12-20 10:00:08 ET More on Health Care Select Sector SPDR XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble For further details see: ...
2023-12-20 08:36:29 ET Losers: Bluebird bio BLUE -52% on pricing of $125 million stock offering . Jin Medical International Ltd ( ZJYL ) -14% . Argen X SE ( ARGX ) -25% reports topline results from address study of Efgartigimod SC in Pemphigus . ...
2023-12-19 17:11:10 ET DENVER, Colo., Dec. 19, 2023 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Compugen Ltd (NASDAQ: CGEN), Gilead Sciences, Inc. (NASDAQ: GILD), Infobird Co Ltd (NASDAQ: IFBD), and Panbela Therapeutics Inc (NASDAQ: PBLA). Comp...
2023-12-19 12:49:04 ET Gainers: Panbela Therapeutics ( PBLA ) +54% . Singlepoint ( SING ) +41% . MedAvail Holdings ( MDVL ) +32% . REE Automotive Ltd ( REE ) +29% . Pulse Biosciences ( PLSE ) +28% . Neonode ( NEON ) +25...
2023-12-19 12:24:05 ET DENVER, Colo., Dec. 19, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Compugen Ltd (NASDAQ: CGEN), Infobird Co Ltd (NASDAQ: IFBD), Mama`s Creations Inc (NASDAQ: MAMA), Panb...
2023-12-18 18:01:11 ET DENVER, Colo., Dec. 18, 2023 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; iCoreConnect Inc (NASDAQ: ICCT), ZimVie Inc (NASDAQ: ZIMV), Panbela Therapeutics Inc (NASDAQ: PBLA), and Cuentas Inc (NASDAQ: CUEN). Today felt like...
2023-12-18 12:22:29 ET DENVER, Colo., Dec. 18, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Invivyd Inc (NASDAQ: IVVD), ZimVie Inc (NASDAQ: ZIMV), Panbela Therapeutics Inc (NASDAQ: PBLA), Esperi...
MINNEAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that US WorldMeds® 1 (USWM), a Kentucky-based spe...
MINNEAPOLIS, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announces the publication of preclinical data from studies of ivospemin...
MINNEAPOLIS, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA) , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announces that the independent Data Safety Monitoring Board (DSMB) of the Phase 3...
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
Panbela Therapeutics Inc Com Website:
DSMB Recommends Continuation without Modification for Third Time Safety Review Included 395 Patients Interim Survival Analysis Still Expected Early 2025 given Lower-Than-Expected Event Rate Low Event Rate Suggests Potential for Prolonged Survival Rapid Enrollment P...
MINNEAPOLIS, June 10, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announces an oral presentation at the Digestive Disease Week (DDW) conference,...
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the q...